BiomarkersHumans
Assessment of the mild behavioral impairment checklist in individuals with subjective cognitive decline and mild cognitive impairment in the BRASCODE cohort
AAIC 2025 Abstract
Abstract
Background: Mild Behavioral Impairment (MBI) is characterized by neuropsychiatric symptoms that may precede cognitive decline in the early stages of neurodegenerative diseases. In Brazil, the study of MBI in individuals with cognitive complaints remains limited.
The paper
Victória Tizeli Souza, Barbara Loeblein Uebel, Gabriela Raquel Paz Rivas, Raphael Machado Castilhos
Show 14 more authors
Simone Sieben da Mota, Bruno de Oliveira De Marchi, Guilherme Da Silva Carvalho, Haniel Bispo De Souza, Lucas Bastos Beltrami, Rhaná Carolina Santos, Sarah Vitoria Bristot Carnevalli, Ana Letícia Amorim de Albuquerque, Leonardo Martins de Paula, Manuella Edler Zandoná Giordani, Wyllians Vendramini Borelli, Giovanna Carello‐Collar, Marcia L. Fagundes Chaves, Eduardo Rigon Zimmer,Universidade Federal do Rio Grande do Sul
AAIC 2025 Abstract · 26 Dec 2025 · CC BY
Presented at AAIC 2025
